| Old Articles: <Older 23331-23340 Newer> |
|---|
 |
The Motley Fool
May 18, 2007
Mike Havrilla |
Innovative Inovio Given the company's strong partnerships and recently strengthened balance sheet, biotech investors should look into Inovio in advance of potentially positive clinical developments for the MedPulser later this year.   |
The Motley Fool
May 18, 2007
Tom Taulli |
Salesforce.com: Building to Last Revenue growth remains robust, but some investors desire greater profitability. |
The Motley Fool
May 18, 2007
Daniel Joshua Rubin |
Fool Video Take: Dial VG for Terror With churn rising, continuing losses, SEC investigations, and fierce competition, fears have been mounting for investors in Vonage. |
The Motley Fool
May 18, 2007
Matt Koppenheffer |
The View From Greenhill A closer look at a highly successful boutique investment bank. Investors, though Greenhill has shown a pretty steady top-line growth rate on an annual basis, quarterly trends reveal how lumpy the realization of advisory and private-equity revenue can be. |
The Motley Fool
May 18, 2007
Timothy M. Otte |
Longs Drug Scores a Winner The West Coast retail drug chain expands its gross margin and beats analyst estimates. |
The Motley Fool
May 18, 2007
Rich Duprey |
Foolish Forecast: A Sporting Chance for Hibbett The regional sporting goods company is set to report its first-quarter 2008 financial results. Investors, here is what you can expect to see. |
The Motley Fool
May 18, 2007
Rich Smith |
Force Protection: Strong, Silent, Superb Investors, this military manufacturer's few words are all good ones. |
The Motley Fool
May 18, 2007
Jeff Hwang |
From the Southern Gaming Summit: Hot Products Investors, here is a look at the hottest new products from the Southern Gaming Summit. Slot Manufacturers... Table Games... Electronic Table Games... etc. |
The Motley Fool
May 18, 2007 |
Nordstrom's Upscale Earnings: Fool by Numbers The upscale retailer released first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
May 18, 2007
Mike Havrilla |
Ample Opportunities for Alnylam The biotech's RNAi pipeline and cutting-edge technology make it a prime takeover candidate. Investors, take note. |
| <Older 23331-23340 Newer> Return to current articles. |
